294 related articles for article (PubMed ID: 10024824)
21. Common clinicopathological features of the patients with chronic hepatitis B virus infection who developed hepatocellular carcinoma after seroconversion to anti-HBs--a consideration of the pathogenesis of HBV-induced hepatocellular carcinoma and a strategy to inhibit it.
Tsuboi Y; Ohkoshi S; Yano M; Suzuki K; Tsubata SS; Ishihara K; Ichida T; Sugitani S; Shibazaki K; Aoyagi Y
Hepatogastroenterology; 2006; 53(67):110-4. PubMed ID: 16506387
[TBL] [Abstract][Full Text] [Related]
22. Natural history of hepatitis B.
Marcellin P; Castelnau C; Martinot-Peignoux M; Boyer N
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):63-75. PubMed ID: 15756147
[TBL] [Abstract][Full Text] [Related]
23. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
24. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
25. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
Trevisani F; Magini G; Santi V; Morselli-Labate AM; Cantarini MC; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
Am J Gastroenterol; 2007 May; 102(5):1022-31. PubMed ID: 17313497
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.
Nguyen VT; Law MG; Dore GJ
J Viral Hepat; 2009 Jul; 16(7):453-63. PubMed ID: 19302335
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
[TBL] [Abstract][Full Text] [Related]
29. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
[TBL] [Abstract][Full Text] [Related]
30. Relationship between hepatocellular carcinoma and cirrhosis.
Kew MC; Popper H
Semin Liver Dis; 1984 May; 4(2):136-46. PubMed ID: 6087459
[TBL] [Abstract][Full Text] [Related]
31. RNA interference-mediated prevention and therapy for hepatocellular carcinoma.
Romano PR; McCallus DE; Pachuk CJ
Oncogene; 2006 Jun; 25(27):3857-65. PubMed ID: 16799627
[TBL] [Abstract][Full Text] [Related]
32. Prevention of liver cancer and cirrhosis by vaccines.
Prince AM
Clin Lab Med; 1996 Jun; 16(2):493-505. PubMed ID: 8792084
[TBL] [Abstract][Full Text] [Related]
33. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
Mun BS; Ahn HS; Ahn DS; Lee SO
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
[TBL] [Abstract][Full Text] [Related]
34. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
[TBL] [Abstract][Full Text] [Related]
35. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
36. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
Nair S; Mason A; Eason J; Loss G; Perrillo RP
Hepatology; 2002 Jul; 36(1):150-5. PubMed ID: 12085359
[TBL] [Abstract][Full Text] [Related]
37. Etiological factor of hepatocellular carcinoma in Italy.
Stroffolini T
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):1-5. PubMed ID: 15756142
[TBL] [Abstract][Full Text] [Related]
38. National survey of hepatocellular carcinoma in heavy drinkers in Japan.
Horie Y; Yamagishi Y; Kajihara M; Kato S; Ishii H
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):32S-36S. PubMed ID: 12960504
[TBL] [Abstract][Full Text] [Related]
39. Prevention of hepatocellular carcinoma in nonviral-related liver diseases.
Fan JG; Farrell GC;
J Gastroenterol Hepatol; 2009 May; 24(5):712-9. PubMed ID: 19646014
[TBL] [Abstract][Full Text] [Related]
40. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]